Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Greenberg Traurig's David Harburger to Speak at 2021 Yale Innovation Summit | ||
| By: PR Newswire Association LLC. - 13 May 2021 | Back to overview list |
|
|
BOSTON, May 12, 2021 /PRNewswire-PRWeb/ -- David S. Harburger, Ph.D., a shareholder in global law firm Greenberg Traurig, LLP's Intellectual Property & Technology and Life Sciences & Medical Technology Practices, will participate in several panels at the 2021 Yale Innovation Summit. Harburger will moderate the Biotech - Pharmaceuticals & Biotherapeutics panels on May 18 and will participate in the Career Development Panel on May 21. Both presentations begin at 1 p.m. EDT. The Yale Innovation Summit is an annual meeting, taking place virtually this year, of venture capital investors and tech innovators. The event, sponsored by Greenberg Traurig, comprises networking opportunities, educational panels, and inspiring presentations, according to the summit's website. The summit will include the opportunity for over 100 startups to pitch their ideas to venture capitalists in hopes of securing funding for their innovations. Harburger, located in Greenberg Traurig's Boston office, is a registered patent attorney working closely with clients from the early stages of formation and beyond to align their intellectual property (IP) strategy with their business goals. He advises biotech clients on patent preparation and prosecution, patent portfolio management, freedom-to-operate, patent invalidity, non-infringement, IP and clinical strategy coordination, and IP due diligence matters. He also advises venture capital and private equity investors in IP related matters in financing rounds. About Greenberg Traurig's Boston Office: Established in 1999, Greenberg Traurig's Boston office is home to approximately 70 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources. About Greenberg Traurig's Life Sciences & Medical Technology Group: Greenberg Traurig's Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group's attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing. About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2200 attorneys 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 3.0 Certified. Web: http://www.gtlaw.com Media Contact Lourdes Brezo Scholl, Greenberg Traurig, LLP, +1 212.801.2131, BrezoSchollL@gtlaw.com
SOURCE Greenberg Traurig, LLP 
|
||
|
|
||
 | Back to overview list | |